| The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma JG Valero, A Matas-Céspedes, F Arenas, V Rodriguez, J Carreras, ... Leukemia 35 (9), 2635-2649, 2021 | 48 | 2021 |
| PI3Kδ inhibition reshapes follicular lymphoma–immune microenvironment cross talk and unleashes the activity of venetoclax N Serrat, M Guerrero-Hernández, A Matas-Céspedes, A Yahiaoui, ... Blood advances 4 (17), 4217-4231, 2020 | 31 | 2020 |
| The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann–Pick type C patients carrying missense mutations J Macías‐Vidal, M Girós, M Guerrero, P Gascón, J Serratosa, O Bachs, ... The FEBS journal 281 (19), 4450-4466, 2014 | 27 | 2014 |
| Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma C Recasens-Zorzo, T Cardesa-Salzmann, P Petazzi, L Ros-Blanco, ... haematologica 104 (4), 778, 2019 | 23 | 2019 |
| Identification of lysosomal Npc1‐binding proteins: Cathepsin D activity is regulated by NPC1 J Macías‐Vidal, M Guerrero‐Hernández, JM Estanyol, C Aguado, ... Proteomics 16 (1), 150-158, 2016 | 19 | 2016 |
| Deciphering the contribution of macrophages to follicular lymphoma pathogenesis: New insights into therapy P Perez Galan, JG Valero, A Matas‐Cespedes, V Rodriguez, F Arenas, ... Hematological Oncology 37, 151-152, 2019 | 2 | 2019 |
| Idelalisib interferes with the crosstalk of follicular lymphoma and its immune microenvironment and potentiates the activity of ABT-199 M Guerrero-Hernandez, A Matas-Cespedes, N Serrat, A Yahiaoui, ... Blood 130, 2813, 2017 | 2 | 2017 |
| The chemokine receptor CXCR4 and the cannabinoid receptor CB2R form heterodimers in non-Hodgkin lymphoma (NHL) and solid tumors leading to functional crosstalk M Guerrero, R Griera, M Perez, G Roué, J Bosch, PJ McCormick, J Camps, ... Cancer Research 76 (14 Supplement), 3288-3288, 2016 | 2 | 2016 |
| The BET Inhibitor GS-626510 Converges with Idelalisib through the Inhibition of Tumor-Macrophage Crosstalk and Cytokine Production in Diffuse Large B-Cell Lymphoma JG Valero, A Chamorro-Jorganes, K Walker, M Guerrero-Hernandez, ... Blood 130, 4108, 2017 | 1 | 2017 |
| Pharmacological modulation of CXCL12-CXCR4 intracellular trafficking potentiates the in vitro and in vivo activity of the BET bromodomain inhibitor CPI203 in diffuse large B … C Recasens-Zorzo, T Cardesa-Salzmann, L Ros-Blanco, A Esteve-Arenys, ... Cancer Research 77 (13 Supplement), 2169-2169, 2017 | 1 | 2017 |
| PI3Kδ inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclax. N Serrat, M Guerrero-Hernández, A Matas-Céspedes, A Yahiaoui, ... | | 2020 |
| Targeting tumor microenvironment crosstalk through GPCR receptors and PI3K pathway M Guerrero Hernández Universitat de Barcelona, 2019 | | 2019 |
| DECIPHERING THE IMPACT OF IDELALISIB ON FOLLICULAR LYMPHOMA AND ITS IMMUNE MICROENVIRONMENT A Matas-Cespedes, M Guerrero, L Magnano, L Grosmaire, A Yahiaoui, ... HAEMATOLOGICA 101, 272-273, 2016 | | 2016 |
| LNCRNA'S IN FOLICULAR LYMPHOMA OF HIGH GRADE ASSOCIATED WITH RELATED PATHWAYS WITH AGGRESSIVENESS BOTH IN TUMOR CELLS AND THE MICROENVIRONMENT L Hernandez Pous, A Roisman, A Navarro Lopez, C Munoz Lozano, ... HAEMATOLOGICA 100, 157-157, 2015 | | 2015 |
